期刊名称：BLOOD CANCER JOURNAL ISSN： 2044-5385 出版频率： Continuous publication 出版社： SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： https://www.macmillanscience.com/en/publishing 期刊网址： http://www.nature.com/bcj/index 影响因子： 11.037 主题范畴： ONCOLOGY;    HEMATOLOGY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to the well-established and highly respected, Leukemia (2011 impact factor 9.561, Journal Citation Reports, Thomson Reuters, 2011), bringing to the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Topics of particular concentration will include, but are not limited to, the following: Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies Murine models Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations Instructions to Authors Aims and scope of journal The impetus of Blood Cancer Journal is the deliberate dissemination of pre-clinical and clinical work in the field of hematology with ramifications into translational biology research down to new therapies. Topics of particular concentration will include, but are not limited to, the following: Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies Murine models Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways. Top of page Abstracted/indexed in Biological Abstracts Biosis Previews Chemical Abstracts Current Contents-Life Sciences Journal Citation Index-Science Science Citation Index-Expanded Scopus Editorial Board Editor-in-Chief Dr Nicole Muller-Bérat Killmann Deputy Editors Dr Ayalew Tefferi Paolo Ghia, MDS. Vincent Rajkumar, MD Associate Editors Christian Buske, University Hospital of Ulm, Germany Gullermo Garcia-Maneroi, University of Texas M.D. Anderson Cancer Center, USA Andreas Hochhaus, University Medical Center Jena, Germany James McCubrey, East Carolina University, USA Mohamad Mohty, CHU de Nantes, France Markus Muschen, University of California, USA Mariusz Ratajczak, University of Louisville, USA Alessandro Vannucchi, University of Florence, Italy Editorial Board Omar Abdel-Wahab, Memorial Sloan-Kettering Cancer Center, USA Stephen Ansell, Mayo Clinic, USA Joseph Antin, Dana-Farber Cancer Institute, USA Januario Castro, Moores UCSD Cancer Center, USA James Chim, University of Hong Kong, China John Crispino, Northwestern University, USA Alessandra Ferrajoli, University of Texas M. D. Anderson Cancer Center, USA Andrés Ferreri, San Raffaele Scientific Institute, Italy Claire Harrison, Guy's and St Thomas' NHS Foundation Trust, UK Marco Herling, University Hospital of Cologne, Germany Teru Hideshima, Dana-Farber Cancer Center, USA Timothy Hughes, Centre for Cancer Biology in Adelaide, Australia Jean-Jacques Kiladjian, Höputal Saint-Louis, France Shaji Kumar, Mayo Clinic, USA Martha Lacy, Mayo Clinic, USA Sagar Lonial, Emory University, USA Robert Marcus, Kings College Hospital, UK Carlos Montalban, University of Alcalá Spain Marco Montillo, Niguarda Ca' Granda Hospital, Italy Toyosi Odenike, University of Chicago, USA Animesh Pardanani, Mayo Clinic, USA Francesco Passamonti, University of Pavia, Italy Farhad Ravandi, University of Texas M. D. Anderson Cancer Center, USA Tadeusz Robak, Medical University of Lodz, Poland Mikkael Sekeres, Cleveland Clinic, USA Tait Shanafelt, Mayo Clinic, USA Michele Spina, National Cancer Institute, Italy Moshe Talpaz, University of Michigan, USA Ellen Weisberg, Dana-Farber Cancer Institute, USA